<DOC>
	<DOC>NCT01063764</DOC>
	<brief_summary>Objective of the First Period: To evaluate the efficacy of Levetiracetam dry syrup at doses up to a maximum of 60 mg/kg/day or 3000 mg/day used as an adjunctive therapy in Japanese pediatric patients (4 to 16 years) with uncontrolled partial seizures despite treatment with 1 or 2 anti-epileptic drug(s).</brief_summary>
	<brief_title>An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures</brief_title>
	<detailed_description>Objectives of the Second Period: To provide the Levetiracetam treatment to subjects who are judged by the investigators to benefit from the long-term treatment and who are willing to continuously receive this drug. To continuously evaluate the safety of the Levetiracetam long-term administration at doses ranging from 20 mg/kg/day or 1000 mg/day to 60 mg/kg/day or 3000 mg/day in subjects who completed the First Period of this study.</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>The patient has partial Epilepsy and the diagnosis must be confirmed in the last 6 months The patients must be on a stable 1 or 2 antiepileptic drug(s) treatment during the 4 weeks prior to Baseline and must have at least 8 partial seizures during the 8week prospective Baseline Period Patient at the age of 4 to 16 years, and at the body weight of 11 to 82 kg The patient has a treatable seizure etiology The patient has Epilepsy secondary to a progressive cerebral disease or any other progressively neurodegenerative disease, including Rasmussen and LandauKleffner diseases The patient has a history of status Epilepticus during the 3 months prior to Visit 1 The patient has a past and present history of pseudo seizures The patient has a current diagnosis of LennoxGastaut syndrome</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Keppra</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Children</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Partial Seizures</keyword>
</DOC>